top of page
AltG IN THE SPOTLIGHT
AltG Quoted In The Economic Times On Mamaearth's Upcoming IPO Analysis
AltG Principals Taponeel Mukherjee and Poornima Vardhan have been quoted in ET Retail On The Upcoming $1.25 Billion MamaEarth's IPO.
"However, according to the note by AltG, the company’s price-to-earnings (P/E) ratio for the IPO stands at 972 based on its 12-month earnings of around Rs 11 crore, which is 23.5 times higher than the industry median P/E ratio of 41.4 for for leading Indian personal care and beauty companies."
In summary, with an astronomical P/E of 972, constrained growth prospects, a valuation of INR 10,500 crores, and trailing twelve-month earnings of around INR 11 crores, there appears to be little room for upside potential in the stock price. Caution is advised for potential investors.
Read the MamaEarth IPO Whitepaper published by AltG here: https://bit.ly/3QeunBX
"However, according to the note by AltG, the company’s price-to-earnings (P/E) ratio for the IPO stands at 972 based on its 12-month earnings of around Rs 11 crore, which is 23.5 times higher than the industry median P/E ratio of 41.4 for for leading Indian personal care and beauty companies."
In summary, with an astronomical P/E of 972, constrained growth prospects, a valuation of INR 10,500 crores, and trailing twelve-month earnings of around INR 11 crores, there appears to be little room for upside potential in the stock price. Caution is advised for potential investors.
Read the MamaEarth IPO Whitepaper published by AltG here: https://bit.ly/3QeunBX
AltG's Capital Allocation Expertise In Nirma's Acquisition Of Glenmark Life Sciences (GLS) for $680 Million
Taponeel Mukherjee and I have been quoted in Business Today On Nirma's $680 Million Landmark Deal.
" All in all, The GLS buyout is a good capital allocation deal for Nirma along with access to the healthcare industry - one of the highest-growth industries in the world."
As per AltG's APEXX Formula, at the current valuation of $900 mm and P/E of 15.26, the 7-year return on invested capital (ROIC) on GLS for Nirma will be 14%, 200 basis points higher than the SENSEX return of ~12% in the last 10 years (from 2013-2023).
Read the Nirma-GLS Whitepaper published by AltG here: https://lnkd.in/dkWZ-vuf
" All in all, The GLS buyout is a good capital allocation deal for Nirma along with access to the healthcare industry - one of the highest-growth industries in the world."
As per AltG's APEXX Formula, at the current valuation of $900 mm and P/E of 15.26, the 7-year return on invested capital (ROIC) on GLS for Nirma will be 14%, 200 basis points higher than the SENSEX return of ~12% in the last 10 years (from 2013-2023).
Read the Nirma-GLS Whitepaper published by AltG here: https://lnkd.in/dkWZ-vuf
What AltG Think Today, Markets Think Tomorrow
AltG had predicted in the CNBC article for Temasek Manipal Deal that consolidation and roll-ups will continue in Indian Hospitals and healthcare. The latest Manipal - AMRI Hospital deal for INR 2300 Crores is in line with this trend.
As Ranjan, Aditya and Manish all agreed with AltG: "AMRI's sale of its hospital business is in the right direction for Emami and value additive for all - Emami, AMRI and Manipal."
Read the detailed article on the behind-the-scenes rationale of the deal in Business Today.
https://bit.ly/3EKmoHD
As Ranjan, Aditya and Manish all agreed with AltG: "AMRI's sale of its hospital business is in the right direction for Emami and value additive for all - Emami, AMRI and Manipal."
Read the detailed article on the behind-the-scenes rationale of the deal in Business Today.
https://bit.ly/3EKmoHD
AltG Ahead Of The Market Again!
The recent development of Tata Consumer, rumoured to be taking a 51% stake in Haldiram's at a $10 Billion valuation, is a testament to AltG's ability to analyze market trends and accurately anticipate industry shifts.
AltG's APEXX formula had called the dominance of Indian QSRs way before the market. In our The Times Of India article in April 2023, we wrote, "Pizzas and Burgers have been the start, but now the opportunity exists in Indian food chains, coffee chains catering to tier-2 and tier-3 cities."
AltG's APEXX formula had called the dominance of Indian QSRs way before the market. In our The Times Of India article in April 2023, we wrote, "Pizzas and Burgers have been the start, but now the opportunity exists in Indian food chains, coffee chains catering to tier-2 and tier-3 cities."
AltG Called PharmEasy's Billion Dollar Valuation Months In Advance; Helps PharmEasy Avoid 90% Down Round
On July 7, 2023, AltG publicly issued their expert opinion in The Economic Times on "The Massive Under-Valuation Of PharmEasy", valuing the company at approximately $1 Billion using their Operational and Capital Allocation expertise.
What AltG Thinks Today, Markets Think Tomorrow:
With AltG indexing the valuation of PharmEasy, stakeholders at the company have benefited immensely. Leading financial media, The Economic Times, quoted AltG saying, "Despite such an urgency, the current down round has puzzled many. PharmEasy's Sum of Parts far exceeds this valuation."
What AltG Thinks Today, Markets Think Tomorrow:
With AltG indexing the valuation of PharmEasy, stakeholders at the company have benefited immensely. Leading financial media, The Economic Times, quoted AltG saying, "Despite such an urgency, the current down round has puzzled many. PharmEasy's Sum of Parts far exceeds this valuation."
" What AltG Thinks Today, Markets Think Tomorrow"
How AltG Predicted the Massive Under-Valuation Of PharmEasy
AltG quoted in The Economic Times article "PharmEasy’s uneasy downround: Not all shareholders happy with prescription" on how we predicted the massive under-valuation of the business and a billionaire's low ball offer to buy them extremely cheap.
AltG quoted in The Economic Times article "PharmEasy’s uneasy downround: Not all shareholders happy with prescription" on how we predicted the massive under-valuation of the business and a billionaire's low ball offer to buy them extremely cheap.
Featured In Business Today - AltG Principals, Poornima Vardhan And Taponeel Mukherjee
In the latest edition of Business Today, Taponeel and Poornima Vardhan opine on the next $55Billion healthcare investment opportunities. While Ravi Lambah, India Head at Temasek expresses the exuberance for Large Indian Hospitals in the article, the question to ask here is - Are they forgetting the key rule of Private Equity? Purchase price matters! While billions of dollars have (and are) chasing the big hospitals, is it possible that the real opportunity is hiding in plain sight?
Poornima Addressing Wharton Students And Faculty
AltG's Principal, Poornima, Addressing The Visiting Wharton Students And Faculty To Discuss Her Experience Of Doing Business In India With AltG.
AltG Featured By INSEAD
Taponeel Mukherjee Featured By INSEAD On His Incredible Work At AltG.
Taponeel Heading The Observer Research Foundation (ORF) Panel
AltG's Principal, Taponeel, Heading The ORF Low Carbon Financing Panel
bottom of page